ARTICLE | Company News
Gilead gets European Cidecin marketing rights
January 8, 2001 8:00 AM UTC
Cubist (CBST) granted GILD exclusive marketing rights to its Cidecin daptomycin antibacterial injection and an oral formulation of daptomycin in Europe. CBST will receive a $13 million upfront licensi...